ERBB2 and breast cancer: Some successes were achieved in the mammary tumors treatment by negatively affecting estrogen (ER) and progesterone (PR) receptors as well as human epidermal growth factor receptor 2 (HER-2) when breast cancers displayed these receptors [3,4,5].